2018 FOCIS-SITC Cancer Immunity and Immunotherapy Course

When:  Jun 20, 2018 from 08:00 to 17:00 (PT)

Presented by the Federation of Clinical Immunology Societies (FOCIS) and the Society for Immunotherapy of Cancer:

Held during the FOCIS Annual Meeting on June 20-23, this course will review tumor immunology as the foundation for the current practice of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations, and opportunities for furthering clinical progress.

8:00 - 9:00 a.m.

The Mechanistic Basis of Cancer Immunotherapy 
Leisha Emens, MD, PhD

9:00 - 9:40 a.m. Manipulating the Tumor Environment (DCs, Tregs, others) 
Max Krummel, PhD
9:40 - 10:00 a.m. Break
10:00 - 10:40 a.m. CAR-T Cell Therapy: Principles and Current Practices
Crystal Mackall, MD
10:40 - 11:20 a.m. CAR-T Cell Therapy: Next Generation CARs Toxicities, Challenges and Prospects
Crystal Mackall, MD
11:20 - noon T-cell Receptor Transduced T-cells
Cassian Yee, MD
12:00 - 12:45 p.m. Lunch with Faculty
12:45 - 1:30 p.m. Checkpoint Blockade Therapy: Current Status & Biomarkers
Ira Mellman, PhD
1:30 - 2:10 p.m. Next Generation Checkpoint and Combination Therapies
Ira Mellman, PhD
2:10 - 2:50 p.m. Focus on Engineered Antibodies (bispecific antibodies, antibody-cytokine fusions and other types of armed antibody products)
Dario Neri, PhD
2:50pm - 3:30pm Immune-Related Toxicity: Mechanisms and Management
Kevan Herold, MD
3:30pm - 3:45pm Break
3:45 - 4:30 p.m. Vaccination Strategies, Identification of Neoantigens
Lisa Butterfield, PhD
4:30 - 5:00 p.m. Future Prospects and Challenges in Cancer Immunotherapy
Jeffrey Bluestone, PhD
This course is made possible through unrestricted education grants from AbbVie, Bristol-Myers Squibb, Genentech, Janssen Research & Development, LLC.

#Adverse Events
#Cellular Therapies


San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103